T1	Participants 133 174	young adults with essential hypertension.
T2	Participants 274 352	young essential hypertension (YEH) patients with abundant phlegm-heat syndrome
T3	Participants 415 564	Twelve male YEH patients were randomly selected and serum samples were collected for examination before and after 4 weeks of the treatment with QRHT.
T4	Participants 565 661	Twelve healthy males were randomly selected and their serum samples were collected as a control.
T5	Participants 1716 1763	YEH patients with abundant phlegm-heat syndrome
